My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Anixa Biosciences, Inc. - Common Stock (NQ:ANIX)

4.380 -0.140 (-3.10%)
Streaming Delayed Price Updated: 1:17 PM EDT, Oct 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 185,077
Open 4.480
Bid (Size) 4.280 (2)
Ask (Size) 4.380 (1)
Prev. Close 4.520
Today's Range 4.208 - 4.494
52wk Range 2.070 - 4.980
Shares Outstanding 32,916,915
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Under-the-Radar Biotechs Under $5 That Could Soar 200%
3 biotech stocks under $5 with cancer, obesity, and psychedelic therapies offer speculative investors high-risk, high-reward potential: HOTH, SILO, and ANIX. 
Via MarketBeat
EXCLUSIVE: Anixa Biosciences Receives Key US Patent Nod For Breast Cancer Vaccine Patent
Anixa secures USPTO patent for its breast cancer vaccine using α-lactalbumin, enhancing its IP portfolio and expanding future immunotherapy options. 
Via Benzinga
Topics Intellectual Property

Performance

YTD
+84.8%
+84.8%
1 Month
+24.4%
+24.4%
3 Month
+36.9%
+36.9%
6 Month
+65.3%
+65.3%
1 Year
+43.6%
+43.6%

More News

Read More
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
EXCLUSIVE: Anixa Biosciences Inks Letter of Intent with Austria-Based VERDI Solutions To Develop AI-Guided Personalized Cancer Vaccines
Via Benzinga
Recap: Anixa Biosciences Q1 Earnings
Via Benzinga
EXCLUSIVE: Anixa Biosciences Poised To Receive US Patent For Ovarian Cancer Vaccine
Via Benzinga
Topics Intellectual Property
This ACNB Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday
Via Benzinga
iAccess Alpha's Buyside Best Ideas Virtual Winter Conference December 10-11, 2024
Via ACCESSWIRE
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Anixa Biosciences And 3 Other Stocks Under $5 Insiders Are Buying
Via Benzinga
EXCLUSIVE: FDA Approves Anixa Biosciences' Individual Patient Trial Application For Ovarian Cancer CAR-T Therapy
Via Benzinga
EXCLUSIVE: Anixa Biosciences Finds Stock Undervalued, Launches $5M Stock Buyback Program
Via Benzinga
ANIX Stock Earnings: Anixa Biosciences Beats EPS for Q2 2024
Via InvestorPlace
7 Penny Biotech Stocks to Triple Your Investment
Via InvestorPlace
Anixa Biosciences, Inc. (NASDAQ: ANIX) Featured in Coverage of the EF Hutton Annual Global Conference
Via Investor Brand Network
Sidoti Events, LLC's Virtual May Micro-Cap Conference
Via ACCESSWIRE
Anixa Biosciences (NASDAQ:ANIX) Gains Attention for Its Innovative Cancer Therapies Amid Biopharma Sector Growth
Via AB Newswire
Sidoti Events, LLC's Virtual January Micro-Cap Conference
Via ACCESSWIRE
Anixa Biosciences, A New Type Of Biotech Company: Could It Disrupt The Cancer Landscape?
Via Benzinga
3 Biotech Stocks to Turn $5,000 Into $1 Million: December 2023
Via InvestorPlace
Anixa Biosciences Reveals Updated Data From Breast Cancer Vaccine Trial, Says 'Exceeded Expectations'
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
The 3 Most Undervalued Cheap Stocks to Buy in September 2023
Via InvestorPlace
Could Anixa Biosciences (NASDAQ:ANIX) Be Developing The Vaccine To End One Of The Deadliest Types Of Breast Cancer?
Via ACCESSWIRE
Could Anixa Biosciences (NASDAQ: ANIX) Be Developing The Vaccine To End One Of The Deadliest Types Of Breast Cancer?
Via Benzinga

Frequently Asked Questions

Is Anixa Biosciences, Inc. - Common Stock publicly traded?
Yes, Anixa Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Anixa Biosciences, Inc. - Common Stock trade on?
Anixa Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Anixa Biosciences, Inc. - Common Stock?
The ticker symbol for Anixa Biosciences, Inc. - Common Stock is ANIX on the Nasdaq Stock Market
What is the current price of Anixa Biosciences, Inc. - Common Stock?
The current price of Anixa Biosciences, Inc. - Common Stock is 4.380
When was Anixa Biosciences, Inc. - Common Stock last traded?
The last trade of Anixa Biosciences, Inc. - Common Stock was at 10/14/25 01:17 PM ET
What is the market capitalization of Anixa Biosciences, Inc. - Common Stock?
The market capitalization of Anixa Biosciences, Inc. - Common Stock is 144.18M
How many shares of Anixa Biosciences, Inc. - Common Stock are outstanding?
Anixa Biosciences, Inc. - Common Stock has 144M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.